Methylated KCNQ5 showed no significant difference of sensitivities among different genders, age groups, stages, tumor locations, tumor sizes, and differentiation statuses, but sensitivities of methylated C9orf50 for detecting CRC of different locations showed statistically significant differences (p<0.05). Here, KCNQ5 is linked to neoplasm.